|
|
Role of transbronchial needle aspiration in mediastinal restaging of ⅢA-N2 non-small cell lung cancer after neoadjuvant chemotherapy |
ZHOU Yao1, ZHUANG Zhi-fang1, JIANG Min-yan2, XUE Zhi-xin3, QIU Tie-feng1, ZHU Xiao-bo2, LING Xia-jun1, MIAO Xiao-hui1, JIANG Yi-ya1, ZHONG Ya-hua1, YIN Xiu-li1, ZHOU Yan-juan1 |
(1.Department of Respiratory, 2.Department of Thoracocardiac Surgery, 3.Department of Pathology, the Affiliated Wujin Hospital of Jiangsu University, Changzhou Jiangsu 213002, China) |
|
|
Abstract Objective: To evaluate the clinical value and safety of transbronchial needle aspiration(TBNA) in mediastinal restaging of non-small cell lung cancer(NSCLC) after neoadjuvant chemotherapy. Methods: In 15 NSCLC patients with suspected N2 lymph node metastasis by chest CT scan, TBNA was performed for two times, before and after chemotherapy. The cytological results were compared with post-operative pathology. Results: Overall diagnostic sensitivity, specificity, accuracy, positive predictive value and negative predictive value of TBNA in mediastinal restaging after neoadjuvant chemotherapy were 80.6%, 100%, 87.2%, 100% and 72.7%. The overall coincidence rate of pathologic typing was 80%. The overall accuracy of c-N by TBNA was 86.7 %(13/15). Serious complications were not observed in all patients. Conclusion: TBNA is an accurate and safe method for mediastinal restaging of NSCLC, which has certain clinical application value.
|
Received: 22 November 2012
|
|
|
|
[1] Sawada S, Yamashita M, Komori E, et al. Current status of adjuvant chemotherapy for resected lung cancer at our institute-focus on clinical trial enrollment[J]. Gan To Kagaku Ryoho, 2010, 37(3): 439-442.[2] Harrow EM, Wang KP. The staging of lung cancer by bronchoscopic transbronchial needle aspiration[J]. Chest Surg Clin N Am, 1996, 6(2): 223-235.[3] Van Schil P, van der Schoot J, Poniewierski J, et al. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer[J]. Lung Cancer, 2002, 37(3): 281-285.[4] International Association for the study of Lung Cancer. Staging manual in thoracic Oncology[M]. Florida:Editorial Rx Press, 2009:15-16.[5] Wang KP. Staging of bronchogenic carcinoma by bronchoscopy[J]. Chest, 1994, 106(2): 588-593.[6] Goldstraw P. Selection of patients for surgery after induction chemotherapy for N2 non-small-cell lung cancer[J]. J Clin Oncol, 2006, 24(21): 3317-3318.[7] Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Clinical prognostic factors in surgically treated stageⅢA-N2 non-small cell lung cancer: analysis of the literature[J]. Lung Cancer, 1998, 19(1): 3-13.[8] Block MI. Transition from mediastinoscopy to endoscopic ultrasound for lung cancer staging[J]. Ann Thorac Surg, 2010, 89(3):885-890. |
|
|
|